16 research outputs found
Preclinical evaluation of a TEX101 protein ELISA test for the differential diagnosis of male infertility
BACKGROUND: TEX101 is a cell membrane protein exclusively expressed by testicular germ cells and shed into seminal plasma. We previously verified human TEX101 as a biomarker for the differential diagnosis of azoospermia, and developed a first-of-its-kind TEX101 ELISA. To demonstrate the clinical utility of TEX101, in this work we aimed at evaluating ELISA performance in a large population of fertile, subfertile, and infertile men. METHODS: Mass spectrometry, size-exclusion chromatography, ultracentrifugation, and immunohistochemistry were used to characterize TEX101 protein as an analyte in seminal plasma. Using the optimized protocol for seminal plasma pretreatment, TEX101 was measured by ELISA in 805 seminal plasma samples. RESULTS: We demonstrated that TEX101 was present in seminal plasma mostly in a free soluble form and that its small fraction was associated with seminal microvesicles. TEX101 median values were estimated in healthy, fertile pre-vasectomy men (5436 ng/mL, N = 64) and in patients with unexplained infertility (4967 ng/mL, N = 277), oligospermia (450 ng/mL, N = 270), and azoospermia (0.5 ng/mL, N = 137). Fertile post-vasectomy men (N = 57) and patients with Sertoli cell-only syndrome (N = 13) and obstructive azoospermia (N = 36) had undetectable levels of TEX101 (≤0.5 ng/mL). A cut-off value of 0.9 ng/mL provided 100% sensitivity at 100% specificity for distinguishing pre- and post-vasectomy men. The combination of a concentration of TEX101 > 0.9 ng/mL and epididymis-specific protein ECM1 > 2.3 μg/mL provided 81% sensitivity at 100% specificity for differentiating between non-obstructive and obstructive azoospermia, thus eliminating the majority of diagnostic testicular biopsies. In addition, a cut-off value of ≥0.6 ng/mL provided 73% sensitivity at 64% specificity for predicting sperm or spermatid retrieval in patients with non-obstructive azoospermia. CONCLUSIONS: We demonstrated the clinical utility of TEX101 ELISA as a test to evaluate vasectomy success, to stratify azoospermia forms, and to better select patients for sperm retrieval. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-017-0817-5) contains supplementary material, which is available to authorized users
IgG-mediated Immune Suppression: the Effect on the Host Immune System
One of the most effective immunological interventions for human disease prevention is the administration of anti-red blood cell (RBC) IgG, more specifically, anti-D IgG, for prevention of hemolytic disease of the fetus and newborn (HDN), a serious and potentially fatal condition caused by the maternal immune response against the Rhesus (Rh) blood group system D antigen on fetal RBC. Despite its widespread clinical use, the mechanism of the suppressive anti-RBC IgG effect is not fully understood. In a murine model of immunity to foreign RBCs, transfusion of mice with IgG-opsonized RBCs strongly attenuated the antibody response compared to transfusion of untreated RBCs. This model was used to study the anti-RBC IgG effect on the host immune response. Contrary to the predominant theories of the anti-D effect, here it is shown that IgG-mediated RBC clearance is not sufficient for the attenuation of antibody responses. IgG-opsonized RBCs internalized by the mononuclear phagocytic cells could stimulate T and B cell responses against RBC antigens. This thesis also shows that the adaptive tolerance at the T or B cell level is not the reason for the attenuation of the antibody response. Instead, IgG selectively prevented the appearance of antigen-primed RBC-specific B cells and, surprisingly, induced the host B cell response against the IgG in complex with RBCs. These results suggest that the inability of RBC-specific B cells to recognize and present RBC-specific epitopes may explain the inhibitory IgG effect.Ph
Electrophoresis-assisted multilayer assembly of nanoparticles for sensitive lateral flow immunoassay
Lateral flow immunoassay (LFIA) is a rapid, simple, and inexpensive method for point-of-need analysis. A major limitation of LFIA is a high limit of detection (LOD), which impacts its diagnostic sensitivity. To overcome this limitation, we introduce a signal-enhancement procedure that is performed after completing LFIA and involves controllably moving biotin- and streptavidin-functionalized gold nanoparticles along the test strip by electrophoresis. The nanoparticles link to immunocomplexes and each other forming multilayer aggregates on the test strip, thus, enhancing the signal. Here, we demonstrate lowering the LOD of hepatitis B surface antigen from approximately 8 to 0.12 ng/mL, making it clinically acceptable. Testing 76 clinical samples of serum and plasma for hepatitis B revealed that signal enhancement increased diagnostic sensitivity of LFIA from 72% to 98% while not affecting its 90% specificity. Electrophoresis-driven detection enhancement of LFIA is universal (antigen-independent), takes two minutes, and can be performed by an untrained person using an inexpensive accessory
Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas
Abstract
Background
Cerebrospinal fluid (CSF) is a proximal fluid which communicates closely with brain tissue, contains numerous brain-derived proteins and thus represents a promising fluid for discovery of biomarkers of central nervous system (CNS) diseases. The main purpose of this study was to generate an extensive CSF proteome and define brain-related proteins identified in CSF, suitable for development of diagnostic assays.
Methods
Six non-pathological CSF samples from three female and three male individuals were selected for CSF analysis. Samples were first subjected to strong cation exchange chromatography, followed by LC-MS/MS analysis. Secreted and membrane-bound proteins enriched in the brain tissues were retrieved from the Human Protein Atlas.
Results
In total, 2615 proteins were identified in the CSF. The number of proteins identified per individual sample ranged from 1109 to 1421, with inter-individual variability between six samples of 21Â %. Based on the Human Protein Atlas, 78 brain-specific proteins found in CSF samples were proposed as a signature of brain-enriched proteins in CSF.
Conclusion
A combination of Human Protein Atlas database and experimental search of proteins in specific body fluid can be applied as an initial step in search for disease biomarkers specific for a particular tissue. This signature may be of significant interest for development of novel diagnostics of CNS diseases and identification of drug targets
The problematic of the culture in Ostrava (the opimon of professionals)
ZámÄ›rem tĂ©to práce je nastĂnit obraz kultury a kulturnĂch vĂ˝znamĹŻ, kterĂ© tvořà souÄŤasnĂ© mÄ›sto Ostrava a pĹ™ilehlĂ˝ širšà region, specifickĂ˝ genius loci a jeho vytvářenĂ, a to zmĂnkou o historii mÄ›sta, dále pomocĂ vybranĂ˝ch kulturnĂch prvkĹŻ, ale pĹ™edevšĂm provedenĂ©ho prĹŻzkumu mezi odbornou veĹ™ejnostĂ z oblasti kultury, kterĂ˝ má za cĂl pokusit se zmapovat jakĂ˝ má a mĹŻĹľe mĂt kultura v souÄŤasnĂ© dobÄ› v tak specifickĂ©m mÄ›stÄ›, jako je Ostrava, vĂ˝znam a v jakĂ©m stavu jsou ostravskĂ© kulturnĂ instituce. Historii zmĂnĂm od prvnĂho osĂdlenĂ v oblasti, prvnĂ pĂsemnĂ© zmĂnky a následnĂ˝ vĂ˝voj ve stĹ™edovÄ›ku aĹľ po vĂ˝znam industriálnĂ revoluce na konci 18. a pĹ™edevšĂm v 19. stoletĂ. V tomto vĂ˝znamnĂ©m obdobĂ se pokusĂm nastĂnit hlavnĂ migraÄŤnĂ pohyby a nálady obyvatel a jejich motivace, zmĂnĂm demografickĂ˝ vĂ˝voj oblasti Ostravska se specifickĂ˝m zpĹŻsobem bydlenĂ a zvyky imigrantĹŻ, kteřà pĹ™icházeli do tohoto regionu. Poukáži na vĂ˝znamnĂ©, pĹ™edevšĂm stavebnĂ a mÄ›stotvornĂ© poÄŤiny v obdobĂ tzv. prvnĂ republiky, dále v obdobĂ po roce 1948, pro srovnánĂ rovněž spĂše z hlediska urbanistickĂ©ho, aĹľ do ukonÄŤenĂ těžby uhlĂ a vĂ˝roby Ĺľeleza na ĂşzemĂ mÄ›sta Ostravy. DomnĂvám se, Ĺľe tyto elementy kultury, kterĂ© mÄ›ly nebo majĂ pro mÄ›sto zásadnĂ vĂ˝znam, pomohou v tĂ©to diplomovĂ© práci syntĂ©zou vytvoĹ™it jako mozaika urÄŤitĂ˝ vjem a povÄ›domĂ o mÄ›stÄ›...
Biochemical and functional characterization of the human tissue kallikrein 9
Human tissue kallikrein 9 (KLK9) is a member of the kallikrein-related family of proteases. Despite its known expression profile, much less is known about the functional roles of this protease and its implications in normal physiology and disease. We present here the first data on the biochemical characterization of KLK9, investigate parameters that affect its enzymatic activity (such as inhibitors) and provide preliminary insights into its putative substrates. We show that mature KLK9 is a glycosylated chymotrypsin-like enzyme with strong preference for tyrosine over phenylalanine at the P1 cleavage position. The enzyme activity is enhanced by Mg2+ and Ca2+, but is reversibly attenuated by Zn2+. KLK9 is inhibited in vitro by many naturally occurring or synthetic protease inhibitors. Using a combination of degradomic and substrate specificity assays, we identified candidate KLK9 substrates in two different epithelial cell lines [the non-tumorigenic human keratinocyte cells (HaCaT) and the tumorigenic tongue squamous carcinoma cells (SCC9)]. Two potential KLK9 substrates [KLK10 and midkine (MDK)] were subjected to further validation. Taken together, our data delineate some functional and biochemical properties of KLK9 for future elucidation of the role of this enzyme in health and disease.</p